Business Description
Beam Therapeutics Inc
NAICS : 325411
SIC : 2833
Compare
Compare
Traded in other countries / regions
BEAM.MexicoBEAM.USA IPO Date
2020-02-06Description
Beam Therapeutics Inc is a biotechnology company engaged in creating genetic medicines based on its base editing technology. This technology enables a new class of genetic medicines that targets a single base in the genome without making a double-stranded break in the DNA. The company's portfolio comprises Gene Correction, Gene Modification, Gene Activation, Gene Silencing, and Multiplex Editing.
Financial Strength
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 6.02 | |||||
| Equity-to-Asset | 0.55 | |||||
| Debt-to-Equity | 0.24 | |||||
| Debt-to-EBITDA | -0.55 | |||||
| Interest Coverage | N/A |
N/A
|
N/A
| |||
| Piotroski F-Score | 4/9 | |||||
| Altman Z-Score | 1.23 | |||||
| Beneish M-Score | -4.67 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year EBITDA Growth Rate | -43.1 | |||||
| 3-Year EPS without NRI Growth Rate | -27.2 | |||||
| 3-Year FCF Growth Rate | 41.3 | |||||
| Future 3-5Y Total Revenue Growth Rate | 4.24 |
Momentum Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 40.28 | |||||
| 9-Day RSI | 34.49 | |||||
| 14-Day RSI | 34.45 | |||||
| 6-1 Month Momentum % | -15.53 | |||||
| 12-1 Month Momentum % | -29.77 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 4.89 | |||||
| Quick Ratio | 4.89 | |||||
| Cash Ratio | 4.82 | |||||
| Days Sales Outstanding | 1797.44 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -16.3 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Operating Margin % | -555.61 | |||||
| Net Margin % | -474.54 | |||||
| ROE % | -37.03 | |||||
| ROA % | -20.54 | |||||
| ROIC % | -79.19 | |||||
| ROC (Joel Greenblatt) % | -144.32 | |||||
| ROCE % | -28.53 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 35.32 | |||||
| PB Ratio | 2.98 | |||||
| Price-to-Tangible-Book | 2.97 | |||||
| Price-to-Operating-Cash-Flow | 76.75 | |||||
| EV-to-EBIT | -3.81 | |||||
| EV-to-Forward-EBIT | -4.87 | |||||
| EV-to-EBITDA | -3.98 | |||||
| EV-to-Forward-EBITDA | -5.53 | |||||
| EV-to-Revenue | 21.2 | |||||
| EV-to-Forward-Revenue | 19.15 | |||||
| EV-to-FCF | -48.58 | |||||
| Price-to-Net-Current-Asset-Value | 4.5 | |||||
| Price-to-Net-Cash | 4.64 | |||||
| Earnings Yield (Greenblatt) % | -26.25 |
How Beam Therapeutics Inc (BEAM) Makes Its Money
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NAS:BEAM
Peter Lynch Chart
Performance
Dividend
Log
Annualized Return %
Total Annual Return %
Beam Therapeutics Inc Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 60.92 | ||
| EPS (TTM) ($) | -4.13 | ||
| Beta | 1.69 | ||
| Volatility % | 84.73 | ||
| 14-Day RSI | 34.45 | ||
| 14-Day ATR ($) | 1.874894 | ||
| 20-Day SMA ($) | 33.0155 | ||
| 12-1 Month Momentum % | -29.77 | ||
| 52-Week Range ($) | 27.77 - 73.27 | ||
| Shares Outstanding (Mil) | 72.4 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 4 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Beam Therapeutics Inc Filings
| Document | Form | Filing Date | ||
|---|---|---|---|---|
| No Filing Data | ||||
Beam Therapeutics Inc Stock Events
| Event | Date | Price($) | ||
|---|---|---|---|---|
| No Event Data | ||||
Beam Therapeutics Inc Frequently Asked Questions
What is Beam Therapeutics Inc(BEAM)'s stock price today?
The current price of BEAM is $30.59. The 52 week high of BEAM is $73.27 and 52 week low is $27.77.
When is next earnings date of Beam Therapeutics Inc(BEAM)?
The next earnings date of Beam Therapeutics Inc(BEAM) is 2023-05-09 Est..
Does Beam Therapeutics Inc(BEAM) pay dividends? If so, how much?
Beam Therapeutics Inc(BEAM) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
